Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Research in rats investigated whether duodenal lesions induced by major venous occlusions can be reduced by BPC 157 peptide regardless nitric oxide (NO) system participation, and came to conclusion, that the peptide quickly avoided occlusion, and could rescue the original duodenal flow
This blend is engineered for controlled laboratory research environments where multiple peptide interactions are studied simultaneously
BPC-157 is a 15-amino-acid synthetic peptide with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, derived from a partial sequence of human gastric juice protein
Most scientists refer to chains with over 100 amino acids as proteins
US$ 28.07
US$ 25.41
US$ 20.32
US$ 20.59
US$ 22.50
US$ 22.07
US$ 23.01
US$ 25.57
![In an earlier analysis of the SURMOUNT-1 trial, tirzepatide (a dual glucose-dependent insulinotropic polypeptide [GIP] and glucagon-like peptide-1 [GLP-1] receptor agonist) was shown to provide substantial and sustained reductions in body weight](https://lookaside.instagram.com/seo/google_widget/crawler/?media_id=3585945231426876830)
